减轻结核病治疗中的不良结果:在案例报告中分析违规风险评估策略
Carolina Rossoni de Melo1, Cláudia Elizabeth Volpe-Chaves2,3, Kássia Raquel da Silva4
1Hospital Universitário Maria Aparecida Pedrossian, Programa de Residência Médica em Doenças Infecciosas e Parasitárias, Campo Grande, Mato Grosso do Sul, Brazil.
Revista do Instituto de Medicina Tropical de Sao Paulo
|October 17, 2024
概括
应对结核病 (TB) 治疗挑战需要全面的,以患者为中心的战略. 这一案例凸显了个性化支持的必要性,特别是对于高风险患者,以防止治疗失败并改善治疗结果.
科学领域:
- 医学 医学 医学 医学 医学
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
背景情况:
- 结核病 (TB) 仍然是一个重要的全球卫生问题,其持续性通常与未解决的护理级联障碍有关.
- 直接观察治疗和单一治疗项目等策略旨在提高坚持,但需要更广泛的医疗团队参与.
研究的目的:
- 检查结核病临床管理中的坚持策略的重要性.
- 分析复发性肺结核 (PTB) 的免疫能力强的患者的不良结果.
主要方法:
- 对2017年至2022年为PTB治疗的免疫能力强患者的案例研究分析.
- 评估治疗的坚持,放弃的风险和患者特定的挑战,包括COVID-19和怀孕.
主要成果:
- 患者经历了治疗失败的持续性Mycobacterium结核病尽管推治疗.
- 包括COVID-19流行病和妊娠复杂管理在内的挑战.
- 该患者的放弃得分风险被重新评估为高风险,导致开始息治疗.
结论:
- 复发性结核病管理是复杂的,即使有明显的坚持.
- 独特的治疗项目,包括心理支持,对于高风险和中等风险患者至关重要.
- 综合,以患者为中心的方法对于成功的结核病治疗和管理至关重要.
相关概念视频
Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.


